These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 31817123)

  • 1. The Effect of Zoledronic Acid on Serum Biomarkers among Patients with Chronic Low Back Pain and Modic Changes in Lumbar Magnetic Resonance Imaging.
    Koivisto K; Karppinen J; Haapea M; Järvinen J; Kyllönen E; Tervonen O; Niinimäki J; Alini M; Lotz J; Dudli S; Samartzis D; Risteli J; Majuri ML; Alenius H; Grad S
    Diagnostics (Basel); 2019 Dec; 9(4):. PubMed ID: 31817123
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of zoledronic acid on type and volume of Modic changes among patients with low back pain.
    Koivisto K; Järvinen J; Karppinen J; Haapea M; Paananen M; Kyllönen E; Tervonen O; Niinimäki J
    BMC Musculoskelet Disord; 2017 Jun; 18(1):274. PubMed ID: 28645291
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of zoledronic acid for chronic low back pain associated with Modic changes in magnetic resonance imaging.
    Koivisto K; Kyllönen E; Haapea M; Niinimäki J; Sundqvist K; Pehkonen T; Seitsalo S; Tervonen O; Karppinen J
    BMC Musculoskelet Disord; 2014 Mar; 15():64. PubMed ID: 24588905
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oral Zoledronic acid bisphosphonate for the treatment of chronic low back pain with associated Modic changes: A pilot randomized controlled trial.
    Shea GKH; Zhang C; Suen WS; Cheung PWH; Cheung JPY; Maatta J; Karppinen J; Samartzis D
    J Orthop Res; 2022 Dec; 40(12):2924-2936. PubMed ID: 35195306
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum biomarkers for Modic changes in patients with chronic low back pain.
    Karppinen J; Koivisto K; Ketola J; Haapea M; Paananen M; Herzig KH; Alini M; Lotz J; Dudli S; Samartzis D; Risteli J; Majuri ML; Alenius H; Kyllönen E; Järvinen J; Niinimäki J; Grad S
    Eur Spine J; 2021 Apr; 30(4):1018-1027. PubMed ID: 33423134
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of Zoledronic Acid and Denosumab in Patients With Low Back Pain and Modic Change: A Proof-of-Principle Trial.
    Cai G; Laslett LL; Aitken D; Halliday A; Pan F; Otahal P; Speden D; Winzenberg TM; Jones G
    J Bone Miner Res; 2018 May; 33(5):773-782. PubMed ID: 29297602
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibiotic treatment In patients with chronic low back pain and Modic changes (the AIM study): study protocol for a randomised controlled trial.
    Storheim K; Espeland A; Grøvle L; Skouen JS; Aßmus J; Anke A; Froholdt A; Pedersen LM; Haugen AJ; Fors T; Schistad E; Lutro O; Marchand GH; Kadar T; Vetti N; Randen S; Nygaard ØP; Brox JI; Grotle M; Zwart JA
    Trials; 2017 Dec; 18(1):596. PubMed ID: 29246188
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Does bone scintigraphy show Modic changes associated with increased bone turnover?
    Järvinen J; Niinimäki J; Karppinen J; Takalo R; Haapea M; Tervonen O
    Eur J Radiol Open; 2020; 7():100222. PubMed ID: 32071952
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bone turnover and periprosthetic bone loss after cementless total hip arthroplasty can be restored by zoledronic acid: a prospective, randomized, open-label, controlled trial.
    Huang TW; Wang CJ; Shih HN; Chang Y; Huang KC; Peng KT; Lee MS
    BMC Musculoskelet Disord; 2017 May; 18(1):209. PubMed ID: 28532408
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between changes in lumbar Modic changes and low back symptoms over a two-year period.
    Järvinen J; Karppinen J; Niinimäki J; Haapea M; Grönblad M; Luoma K; Rinne E
    BMC Musculoskelet Disord; 2015 Apr; 16():98. PubMed ID: 25897658
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intravenous Zoledronic Acid 5 mg on Bone Turnover Markers and Bone Mineral Density in East China Subjects with Newly Diagnosed Osteoporosis: A 24-month Clinical Study.
    Liang BC; Shi ZY; Wang B; Wu P; Kong LC; Yao JL; Li CW; Shi XL
    Orthop Surg; 2017 Feb; 9(1):103-109. PubMed ID: 28276638
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlation of size and type of modic types 1 and 2 lesions with clinical symptoms: a descriptive study in a subgroup of patients with chronic low back pain on the basis of a university hospital patient sample.
    Kääpä E; Luoma K; Pitkäniemi J; Kerttula L; Grönblad M
    Spine (Phila Pa 1976); 2012 Jan; 37(2):134-9. PubMed ID: 21415809
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chronic low back pain in relation to Modic changes, bony endplate lesions, and disc degeneration in a prospective MRI study.
    Luoma K; Vehmas T; Kerttula L; Grönblad M; Rinne E
    Eur Spine J; 2016 Sep; 25(9):2873-81. PubMed ID: 27480265
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of intravenous zoledronic acid plus subcutaneous teriparatide [rhPTH(1-34)] in postmenopausal osteoporosis.
    Cosman F; Eriksen EF; Recknor C; Miller PD; Guañabens N; Kasperk C; Papanastasiou P; Readie A; Rao H; Gasser JA; Bucci-Rechtweg C; Boonen S
    J Bone Miner Res; 2011 Mar; 26(3):503-11. PubMed ID: 20814967
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative effect of zoledronic acid versus denosumab on serum sclerostin and dickkopf-1 levels of naive postmenopausal women with low bone mass: a randomized, head-to-head clinical trial.
    Anastasilakis AD; Polyzos SA; Gkiomisi A; Bisbinas I; Gerou S; Makras P
    J Clin Endocrinol Metab; 2013 Aug; 98(8):3206-12. PubMed ID: 23788684
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hybrid Bone Single Photon Emission Computed Tomography Imaging in Evaluation of Chronic Low Back Pain: Correlation with Modic Changes and Degenerative Disc Disease.
    Russo VM; Dhawan RT; Dharmarajah N; Baudracco I; Lazzarino AI; Casey AT
    World Neurosurg; 2017 Aug; 104():816-823. PubMed ID: 28377243
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of antibiotic treatment in patients with chronic low back pain and Modic changes (the AIM study): double blind, randomised, placebo controlled, multicentre trial.
    Bråten LCH; Rolfsen MP; Espeland A; Wigemyr M; Aßmus J; Froholdt A; Haugen AJ; Marchand GH; Kristoffersen PM; Lutro O; Randen S; Wilhelmsen M; Winsvold BS; Kadar TI; Holmgard TE; Vigeland MD; Vetti N; Nygaard ØP; Lie BA; Hellum C; Anke A; Grotle M; Schistad EI; Skouen JS; Grøvle L; Brox JI; Zwart JA; Storheim K;
    BMJ; 2019 Oct; 367():l5654. PubMed ID: 31619437
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Usefulness of Bone Biomarkers for Monitoring Treatment Disease: A Comparative Study in Osteolytic and Osteosclerotic Bone Metastasis Models.
    Martín-Fernández M; Valencia K; Zandueta C; Ormazábal C; Martínez-Canarias S; Lecanda F; de la Piedra C
    Transl Oncol; 2017 Apr; 10(2):255-261. PubMed ID: 28214773
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Type 1 Modic changes was a significant risk factor for 1-year outcome in sick-listed low back pain patients: a nested cohort study using magnetic resonance imaging of the lumbar spine.
    Jensen OK; Nielsen CV; Sørensen JS; Stengaard-Pedersen K
    Spine J; 2014 Nov; 14(11):2568-81. PubMed ID: 24534386
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Are the presence of MODIC changes on MRI scans related to "improvement" in low back pain patients treated with lumbar facet joint injections?
    Bianchi M; Peterson CK; Pfirrmann CW; Hodler J; Bolton J
    BMC Musculoskelet Disord; 2015 Sep; 16():234. PubMed ID: 26338033
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.